Compared with IPF with a chronic clinical course (n = 10), DM-ILD with a chronic clinical course (n = 9) showed significantly higher expression of C3c (p = 0.011), IgG (p = 0.037) and IgM (p = 0.001). This evidence concerns the gene CD40LG and dermatomyositis.